20Med Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

20Med Therapeutics General Information

Description

Developer of polymer nanoparticle technology intended to support the development of prophylactic and therapeutic vaccines. The company's technology offers polymeric nanoparticles with a combination of chemical and biological properties that help in protecting fragile payloads, transport, cellular uptake, and release of active oligonucleotide-based payloads into the cytoplasm of target cells, enabling healthcare organizations to treat gene-related diseases and gene therapy in a clinical setting effectively.

Contact Information

Website
www.20medtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Drienerlolaan 5
  • 7522 NB Enschede
  • Netherlands
+31 053
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Drienerlolaan 5
  • 7522 NB Enschede
  • Netherlands
+31 053

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

20Med Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 22-May-2023 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
5. Grant 01-Sep-2020 Completed Generating Revenue
4. Later Stage VC 01-Jan-2018 Completed Generating Revenue
3. Grant 01-Jan-2017 Completed Generating Revenue
2. Debt - General 25-Jul-2014 $339K $339K Completed Generating Revenue
1. University Spin-Out 01-Jan-2011 Completed Startup
To view 20Med Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

20Med Therapeutics Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

20Med Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4490220-A1 Azanaphthalene-functionalized polymers for gene and drug delivery Pending 09-Mar-2022
US-20250207150-A1 Azanaphthalene-functionalized polymers for gene and drug delivery Pending 09-Mar-2022
EP-4489733-A1 Polymer-coated nanoparticles Pending 09-Mar-2022
US-20250195442-A1 Polymer-coated nanoparticles Pending 09-Mar-2022
ES-2582324-T3 Nanogeles Active 27-May-2011 A61K47/34
To view 20Med Therapeutics’s complete patent history, request access »

20Med Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

20Med Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Coalition for Epidemic Preparedness Innovations Impact Investing Minority
unlock_ Accelerator/Incubator
Oost NL Venture Capital Minority
Twente Technology Fund Venture Capital Minority
European Commission Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

20Med Therapeutics FAQs

  • When was 20Med Therapeutics founded?

    20Med Therapeutics was founded in 2011.

  • Where is 20Med Therapeutics headquartered?

    20Med Therapeutics is headquartered in Enschede, Netherlands.

  • What is the size of 20Med Therapeutics?

    20Med Therapeutics has 11 total employees.

  • What industry is 20Med Therapeutics in?

    20Med Therapeutics’s primary industry is Drug Delivery.

  • Is 20Med Therapeutics a private or public company?

    20Med Therapeutics is a Private company.

  • What is 20Med Therapeutics’s current revenue?

    The current revenue for 20Med Therapeutics is .

  • How much funding has 20Med Therapeutics raised over time?

    20Med Therapeutics has raised $4.25M.

  • Who are 20Med Therapeutics’s investors?

    Coalition for Epidemic Preparedness Innovations, unlock_, Oost NL, Twente Technology Fund, and European Commission are 5 of 6 investors who have invested in 20Med Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »